‘Life-changing’: New drug to save MS sufferers $28k

Listing of the drug, known as Kesimpta, is expected to save a multiple sclerosis patient up to $28,000 a year and is the only B-cell therapy that can be self-administered at home instead of through a transfusion. Multiple sclerosis is a disease that causes the immune system to attack the central…



Click here to view the original article.